Good evening :)
Add to Watchlist
Share

How to use scorecard? Learn more

Nippon India Pharma Fund

Growth
EquitySectoral Fund - Pharma & Health Care
Large-size FundAssets Under Mgmt: ₹ 8,638 Cr
Very High RiskPrinciple investment will be at very high risk
568.730.66% (-3.78)

Price Chart

High
Low
Returns
0.00%
1M
6M
1Y
3Y
5Y
Max
SIP
Loading...
1M
6M
1Y
3Y
5Y
Max
SIP

How to use scorecard? Learn more

EquitySectoral Fund - Pharma & Health Care
Large-size FundAssets Under Mgmt: ₹ 8,638 Cr
Very High RiskPrinciple investment will be at very high risk

Key Metrics

Expense RatioExpense RatioNo LabelNo LabelNo LabelNo Label
0.9152.562.45
No LabelNo LabelNo LabelNo LabelNo LabelNo Label
1.4751.682.58

Scheme Info

PlanPlanLock inLock inExit LoadExit Load
Growth0 yrs1.00%
1% on or before 1M Nil after 1M
SIP Inv.SIP Inv.Min. LumpsumMin. Lumpsum
Allowed₹ 5,000
Initial: ₹ 5,000 Incremental: ₹ 1,000
BenchmarkBenchmark
BSE Health Care - TRI

About Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

Peers & Comparison

Comparing 3 mutual funds from 
EquitySectoral Fund - Pharma & Health Care
Loading...
Mutual Fund1Y Returns1Y Returns3Y CAGR3Y CAGRLife CAGRLife CAGR
Nippon India Pharma Fund38.23%20.89%19.20%
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund50.18%25.71%24.86%
SBI Healthcare Opp Fund48.66%26.20%19.22%
DSP Healthcare Fund47.88%24.12%28.51%

Price Comparison

Compare Nippon India Pharma Fund with any MF, ETF, stock or index
Compare Nippon India Pharma Fund with any MF, ETF, stock or index
Nippon India Pharma Fund
Hmm, looks like data is unavailable here. Please come back after some time
Loading...

Asset Allocation

Actual

Target

Mar 2024

Jun 2024

Sep 2024

Nov 2024

ACTUAL
Cash & EquivalentsEquity3.07%96.93%

Mar 2024

Jun 2024

Sep 2024

Nov 2024

Tickertape Separator

Sector Distribution

OthersMiscellaneousLabs & Life Sciences ServicesPharmaceuticals1.08 %3.22 %17.47 %78.24 %

Mar 2024

Jun 2024

Sep 2024

Nov 2024

Tickertape Separator

Sector Weightage

Sep 23Dec 23Mar 24Jun 24Sep 24Nov 2480.19%80.53%80.92%81.93%79.13%78.24%
Pharmaceuticals as a % of total holdings for last six quarters
Tickertape Separator

Current Holdings

Equity

Others

  • Constituent
    Holding Weight
    3M Change
  • Sun Pharmaceutical Industries Ltd
    SUNPHARMA
    3M change : -0.29 %

    Holdings

    13.52 %

    -0.29 %
  • Divi's Laboratories Ltd
    DIVISLAB
    3M change : 1.70 %

    Holdings

    9.65 %

    1.70 %
  • Lupin Ltd
    LUPIN
    3M change : -0.69 %

    Holdings

    7.61 %

    -0.69 %

AMC Profile

Nippon India Mutual Fund is one of India’s leading mutual funds, with Average Assets Under Management (AAUM) of Rs 2,79,431 Crores​​. NIMF has been established as a trust under the Indian Trusts Act, 1882 with Nippon Life Insurance Company as its Sponsor and Nippon Life India Trustee Ltd as its Trustee.

  • No.of Schemes

    80

  • Total AUM

    ₹ 4,23,860.25 Cr.

Fund Manager Profile

Sailesh Raj Bhan

AUM:  ₹82,952.51 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp: 10yrs

Qualification

MBA (Finance), CFA (ICFAI)

Past Experience

Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date

Manager Performance (0)

Loading...

Tax Implications

Invested period < 1 year

Gains are treated as short-term capital gains and taxed at 20%

Invested period > 1 year

Gains are treated as long-term capital gains and taxed at 12.5%

Let’s calculate your returns after tax

Investment frequency

Monthly

One Time

Monthly Investment Amt. (₹)

Investment period (years)

CAGR (%)
This CAGR is calculated based on the actual past return given by the fund during the selected investment period. This is the annualised growth rate assuming monthly compounding.

+

-

You make

Opinions and Fund Reviews

The content here in the form of articles and videos is for information purposes only and may have been sourced from publicly available sources or otherwise. Tickertape does not guarantee the authenticity and veracity of the material shared. The User understands and agrees that Tickertape is not aware nor liable for any content shared here.